55
ALZHEON, INC. raises $78.8M under Reg D
Company raise · Raising · Offering $500M · Sold $78.8M · FRAMINGHAM, MA · filed 2026-09-10
35
ALZHEON, INC. files Form D
Company raise update · Raising · FRAMINGHAM, MA · Form D/A filed 2025-02-10
$50M+ raise
Why now — by persona
Relevant to: B2B software & services sales. Lead card pending.
People on the filing
| Diane K. Jorkasky, M.D. | Director |
| Muneer E. Satter | Director |
| Neil W. Flanzraich | Director |
| Glenn E. Pauly | Chief Commercial Officer |
| Susan K. Abushakra, M.D. | Chief Medical Officer |
| John K. Hey, Ph.D. | Chief Scientific Officer |
| Kenneth A. Mace | Treasurer and Chief Financial Officer |
| Martin Tolar, M.D., Ph.D. | President and Chief Executive Officer |
| Gino K. Santini | Director |
| Christopher Noel Dunn | Director |
| Adem E. Albayrak | Chief Data Officer |
| Jordan W. Heller | Director |
| Aidan K. Power, MRCPsych | Chief Development Officer |
Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
35
ALZHEON, INC. files Form D
Company raise update · Closed · Offering $125M · Sold $125M · FRAMINGHAM, MA · filed 2025-01-02